PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28677768-0	2017	Thromboxane A2 receptor antagonist SQ29548 suppresses the LPS-induced release of inflammatory cytokines in BV2 microglia cells via suppressing MAPK and NF-kappaB signaling pathways.	SQ 29548	35-42	toll-like receptor 4	Mus musculus	58-61	
28677768-3	2017	In the present study, the anti-inflammatory effects of SQ29548 on lipopolysaccharide (LPS)-stimulated BV2 microglial cells and its molecular mechanisms were investigated.	SQ 29548	55-62	toll-like receptor 4	Mus musculus	86-89	
28677768-5	2017	In vitro studies demonstrated that SQ29548 inhibited LPS-stimulated BV2 activation and reduced the mRNA expression levels of interleukin (IL)-1beta, IL-6, tumor necrosis factor-alpha and inducible NO synthase via inhibition of MAPKs and the NF-kappaB signaling pathway.	SQ 29548	35-42	toll-like receptor 4	Mus musculus	53-56	
28677768-6	2017	SQ29548 inhibited the LPS-induced inflammatory response by blocking MAPKs and NF-kappaB activation in BV2 microglial cells.	SQ 29548	0-7	toll-like receptor 4	Mus musculus	22-25